Orexigen Therapeutics Inc (NASDAQ:OREX)

4.93
Delayed Data
As of May 27
 -0.015 / -0.30%
Today’s Change
3.11
Today|||52-Week Range
9.37
-18.65%
Year-to-Date

Today’s Trading

Previous close4.95
Today’s open4.95
Day’s range-- - --
Volume1,447,846
Average volume (3 months)6,139,970
Market cap$619.2M
Dividend yield--
Data as of 05/27/2015

Growth & Valuation

Earnings growth (last year)+60.00%
Earnings growth (this year)-103.34%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+1,519.63%
P/E ratioNM
Price/Sales12.91
Price/Book27.32

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...+0.03+0.52%
--China Health Group I...-0.01-1.47%
RVNCRevance Therapeutics...+0.10+0.39%
SUPNSupernus Pharmaceuti...+0.31+2.35%
Data as of 05/27/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$55.5M
Annual profit (last year)-$37.5M
Net profit margin-67.59%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
CFO, Treasurer &
Chief Business Officer
Joseph P. Hagan
Corporate headquarters
La Jolla, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers